Bill Text: VA HB312 | 2020 | Regular Session | Prefiled
Bill Title: Naloxone or other opioid antagonist; communication of information by Board of Pharmacy.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2020-01-28 - Stricken from docket by Health, Welfare and Institutions (22-Y 0-N) [HB312 Detail]
Download: Virginia-2020-HB312-Prefiled.html
20101561D
HOUSE BILL NO. 312
Offered January 8, 2020
Prefiled December 31, 2019
A BILL to amend the Code of Virginia by adding in Article 2 of Chapter 33 of Title 54.1 a section numbered
54.1-3309.1, relating to Board of Pharmacy; communication
of information about naloxone.
----------
Patron-- Gooditis
----------
Committee Referral Pending
----------
Be it enacted by the General Assembly of Virginia:
1. That the Code of Virginia is amended by adding in Article 2 of Chapter 33 of Title 54.1 a section numbered 54.1-3309.1 as follows:
§ 54.1-3309.1. Information about naloxone or other opioid antagonist.
The Board shall include in each annual license renewal communication information about the dispensing, possession, and administration of naloxone or other opioid antagonist, including information about laws governing the dispensing, possession, and administration of naloxone or other opioid antagonist and civil immunity for individuals who administer naloxone or other opioid antagonist to a person believed to be experiencing an opioid overdose.
